Cargando…
Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants
Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072023/ https://www.ncbi.nlm.nih.gov/pubmed/33912197 http://dx.doi.org/10.3389/fimmu.2021.677572 |
_version_ | 1783683834374520832 |
---|---|
author | Totsune, Eriko Nakano, Tomohiro Moriya, Kunihiko Sato, Daichi Suzuki, Dai Miura, Akinobu Katayama, Saori Niizuma, Hidetaka Kanno, Junko van Zelm, Menno C. Imai, Kohsuke Kanegane, Hirokazu Sasahara, Yoji Kure, Shigeo |
author_facet | Totsune, Eriko Nakano, Tomohiro Moriya, Kunihiko Sato, Daichi Suzuki, Dai Miura, Akinobu Katayama, Saori Niizuma, Hidetaka Kanno, Junko van Zelm, Menno C. Imai, Kohsuke Kanegane, Hirokazu Sasahara, Yoji Kure, Shigeo |
author_sort | Totsune, Eriko |
collection | PubMed |
description | Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was LRBA. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the LRBA gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency. |
format | Online Article Text |
id | pubmed-8072023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80720232021-04-27 Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants Totsune, Eriko Nakano, Tomohiro Moriya, Kunihiko Sato, Daichi Suzuki, Dai Miura, Akinobu Katayama, Saori Niizuma, Hidetaka Kanno, Junko van Zelm, Menno C. Imai, Kohsuke Kanegane, Hirokazu Sasahara, Yoji Kure, Shigeo Front Immunol Immunology Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was LRBA. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the LRBA gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8072023/ /pubmed/33912197 http://dx.doi.org/10.3389/fimmu.2021.677572 Text en Copyright © 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Totsune, Eriko Nakano, Tomohiro Moriya, Kunihiko Sato, Daichi Suzuki, Dai Miura, Akinobu Katayama, Saori Niizuma, Hidetaka Kanno, Junko van Zelm, Menno C. Imai, Kohsuke Kanegane, Hirokazu Sasahara, Yoji Kure, Shigeo Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants |
title | Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants |
title_full | Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants |
title_fullStr | Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants |
title_full_unstemmed | Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants |
title_short | Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants |
title_sort | case report: infantile-onset fulminant type 1 diabetes mellitus caused by novel compound heterozygous lrba variants |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072023/ https://www.ncbi.nlm.nih.gov/pubmed/33912197 http://dx.doi.org/10.3389/fimmu.2021.677572 |
work_keys_str_mv | AT totsuneeriko casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT nakanotomohiro casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT moriyakunihiko casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT satodaichi casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT suzukidai casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT miuraakinobu casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT katayamasaori casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT niizumahidetaka casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT kannojunko casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT vanzelmmennoc casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT imaikohsuke casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT kaneganehirokazu casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT sasaharayoji casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants AT kureshigeo casereportinfantileonsetfulminanttype1diabetesmellituscausedbynovelcompoundheterozygouslrbavariants |